TWD 19.65
(-0.51%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 204.4 Million TWD | -23.08% |
2022 | 265.72 Million TWD | 25.92% |
2021 | 211.02 Million TWD | 63.68% |
2020 | 128.92 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 204.4 Million TWD | 206.53% |
2024 Q2 | 24.71 Million TWD | -87.91% |
2023 Q3 | 66.68 Million TWD | 87.74% |
2023 FY | 204.4 Million TWD | -23.08% |
2023 Q4 | 66.68 Million TWD | 0.0% |
2023 Q2 | 35.51 Million TWD | 0.0% |
2023 Q1 | 35.51 Million TWD | -22.12% |
2022 FY | 265.72 Million TWD | 25.92% |
2022 Q4 | 45.61 Million TWD | 0.0% |
2021 FY | 211.02 Million TWD | 63.68% |
2020 FY | 128.92 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Lytone Enterprise, Inc. | 28.66 Million TWD | -613.164% |
Vetnostrum Animal Health Co., Ltd. | 91.6 Million TWD | -123.152% |